Sermorelin 10mg

Sermorelin 10mg

Product Name: Sermorelin

Alternative Name: GRF 1-29, GHRH (1-29)

Research Category: Growth Hormone-Releasing Hormone (GHRH) Analog / Endocrine Research Peptide

CAS Number: 86168-78-7

Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂S

Molecular Weight: Approximately 3357.9 g/mol

Peptide Type: Synthetic 29-Amino-Acid Peptide

Research Target: Growth Hormone-Releasing Hormone Receptor (GHRHR)

Research Interest: Growth hormone secretion, pituitary signaling, GH/IGF-1 axis, endocrine physiology, and growth hormone-releasing pathways.

Description

Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of human growth hormone-releasing hormone (GHRH). This sequence represents the biologically active region of GHRH and has been studied for its ability to stimulate endogenous growth hormone secretion through pituitary signaling.

Mechanism of Research

Sermorelin acts as an agonist of growth hormone-releasing hormone receptors located on pituitary somatotroph cells. Activation of these receptors stimulates signaling pathways associated with the synthesis and release of endogenous growth hormone, which can subsequently influence the GH/IGF-1 endocrine axis.

Research Applications

Research involving Sermorelin includes pituitary function, growth hormone secretion, GHRH receptor signaling, GH/IGF-1 regulation, endocrine physiology, and biological pathways associated with pulsatile growth hormone release.

Storage

Storage requirements depend on the formulation and chemical form supplied. Research material should be stored according to the accompanying certificate of analysis (COA), product specification sheet, and manufacturer instructions.

Research Use Disclaimer

This information is provided for scientific and research reference purposes only and should not be interpreted as medical, prescribing, or dosing advice.